27Feb 2025
Advanced Lipoprotein Profiling Enhances CV Risk Prediction in T2D

Advanced Lipoprotein Profiling Enhances CV Risk Prediction in T2D

The LIPOCAT study analyzed 933 type 2 diabetes (T2D) patients using advanced 1H-NMR lipoprotein and glycoprotein profiling. Elevated VLDL-C, IDL-TG, LDL-TG, and glycoproteins A and B were linked to cardiovascular events (CVE). Adding these advanced biomarkers to traditional models improved CVE prediction, with AUROC reaching 0.756. Findings were validated in an independent cohort.

  • #cardiology

Like

Save

Share